News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,385 Results
Type
Article (39713)
Company Profile (247)
Press Release (659425)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (204177)
Career Advice (2007)
Deals (35421)
Drug Delivery (95)
Drug Development (81048)
Employer Resources (172)
FDA (16185)
Job Trends (14861)
News (345207)
Policy (32542)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49441)
ALS (91)
Alzheimer's disease (1380)
Antibody-drug conjugate (ADC) (129)
Approvals (16187)
Artificial intelligence (257)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (285)
Cancer (2290)
Cardiovascular disease (179)
Career advice (1677)
Career pathing (30)
CAR-T (152)
Cell therapy (429)
Cervical cancer (20)
Clinical research (66041)
Collaboration (846)
Company closure (1)
Compensation (551)
Complete response letters (19)
COVID-19 (2589)
CRISPR (41)
C-suite (249)
Cystic fibrosis (101)
Data (2271)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (275)
Diagnostics (6374)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (86790)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112532)
Executive appointments (734)
FDA (17503)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (761)
Gene editing (109)
Generative AI (19)
Gene therapy (308)
GLP-1 (713)
Government (4420)
Grass and pollen (4)
Guidances (108)
Healthcare (18816)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2733)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (312)
IPO (16517)
IRA (40)
Job creations (3632)
Job search strategy (1422)
Kidney cancer (10)
Labor market (40)
Layoffs (471)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (322)
Lymphoma (155)
Machine learning (8)
Management (58)
Manufacturing (318)
MASH (70)
Medical device (13380)
Medtech (13385)
Mergers & acquisitions (19465)
Metabolic disorders (698)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1923)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (40)
Obesity (370)
Opinion (204)
Ovarian cancer (77)
Pain (90)
Pancreatic cancer (88)
Parkinson's disease (149)
Partnered (21)
Patents (239)
Patient recruitment (115)
Peanut (46)
People (57331)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20574)
Phase II (29087)
Phase III (21662)
Pipeline (1277)
Policy (143)
Postmarket research (2563)
Preclinical (8748)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (380)
Real estate (5907)
Recruiting (65)
Regulatory (22310)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (130)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3578)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (45)
The Weekly (30)
Vaccines (693)
Venture capitalists (41)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Today (290)
Last 7 days (862)
Last 30 days (2900)
Last 365 days (32638)
2025 (11277)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46540)
2018 (35019)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29264)
2010 (27328)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37863)
Australia (6186)
California (6261)
Canada (2039)
China (530)
Colorado (269)
Connecticut (275)
Delaware (153)
Europe (81335)
Florida (928)
Georgia (208)
Idaho (57)
Illinois (544)
India (25)
Indiana (313)
Iowa (11)
Japan (167)
Kansas (104)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (908)
Massachusetts (4666)
Michigan (222)
Minnesota (396)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (65)
New Hampshire (63)
New Jersey (1760)
New Mexico (28)
New York (1774)
North Carolina (979)
North Dakota (8)
Northern California (2747)
Ohio (207)
Oklahoma (14)
Oregon (34)
Pennsylvania (1402)
Puerto Rico (12)
Rhode Island (33)
South America (1097)
South Carolina (25)
South Dakota (1)
Southern California (2351)
Tennessee (103)
Texas (932)
United States (23551)
Utah (185)
Virginia (150)
Washington D.C. (64)
Washington State (556)
West Virginia (3)
Wisconsin (56)
699,385 Results for "ecolab inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ecolab Delivers Very Strong First Quarter Performance
Ecolab Delivers Very Strong First Quarter Performance.
April 30, 2024
·
30 min read
Business
Ecolab Schedules Webcast and Conference Call on April 30th
Ecolab will host a live webcast of its first quarter earnings conference call to discuss 2024 first quarter results.
March 19, 2024
·
1 min read
Press Releases
Medline completes successful acquisition of surgical solutions business from Ecolab Inc.
August 2, 2024
·
2 min read
Business
Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing
Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes.
June 3, 2024
·
4 min read
Business
Baker to Retire From Ecolab Board
Ecolab announced that Douglas M. Baker, Jr., executive chairman of the board of directors of Ecolab, has informed the company that he will step down from the board following the expiration of his current term at Ecolab’s 2022 Annual Meeting of Shareholders on May 5, 2022.
February 28, 2022
·
2 min read
Deals
Ecolab Declares Regular Dividend
The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.51 per common share, to be paid April 15, 2022, to shareholders of record at the close of business on March 15, 2022.
February 24, 2022
·
1 min read
BioMidwest
Ecolab Life Sciences Announces 12% Price Increase
Ecolab Inc. will begin implementing a price increase for all Life Sciences division offerings, effective February 1, 2022, due to the significant and ongoing global supply chain disruptions and cost increases, including those for raw materials, logistics and labor.
January 21, 2022
·
2 min read
BioMidwest
Ecolab Announces a Temporary Global 8%-12% Energy Surcharge
Ecolab Inc. (NYSE:ECL) announced a temporary 8%-12% energy surcharge on all of its global products, effective April 1, 2022.
March 15, 2022
·
4 min read
BioMidwest
Ecolab Celebrates New Water Stewardship Certifications on World Water Day
Ecolab Inc. has increased its portfolio of Alliance for Water Stewardship (AWS) certified sites, adding two manufacturing plants in Lerma and Cuautitlan Izcalli, Mexico.
March 22, 2022
·
3 min read
Press Releases
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
May 7, 2025
·
3 min read
1 of 69,939
Next
